tiprankstipranks
Advertisement
Advertisement
Tiziana Life Sciences doses last patient in intranasal foralumab trial
PremiumThe FlyTiziana Life Sciences doses last patient in intranasal foralumab trial
1M ago
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
Premium
The Fly
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
2M ago
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
Premium
Company Announcements
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
2M ago
Tiziana Life Sciences announces updated intranasal foralumab data
PremiumThe FlyTiziana Life Sciences announces updated intranasal foralumab data
3M ago
Tiziana Life Sciences Reports Positive Expanded Access Data for Intranasal Foralumab in Progressive MS
Premium
Company Announcements
Tiziana Life Sciences Reports Positive Expanded Access Data for Intranasal Foralumab in Progressive MS
3M ago
Tiziana Phase 2 trial for foralumab shows reduced brain inflammation
Premium
The Fly
Tiziana Phase 2 trial for foralumab shows reduced brain inflammation
3M ago
Tiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress
PremiumCompany AnnouncementsTiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress
4M ago
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
Premium
Company Announcements
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
4M ago
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
Premium
Company Announcements
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100